MBIO
MUSTANG BIO, INC.
-0.01 (-1.94%)0.49USD7.9K成交股數12.2M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | 04-27 | Litchman Manuel MD | President, CEO and Interim CFO | F 繳稅扣股 | 19 | 0.75 | 14.25 | 1.6K | SEC |
| 2026-01-02 | 01-05 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 278K | – | – | 537K | SEC |
| 2025-12-30 | 12-30 | Chill Adam J. | Director | S 公開市場賣出 | 4 | 0.95 | 3.80 | 375 | SEC |
| 2025-12-30 | 12-30 | Herskowitz Neil | Director | S 公開市場賣出 | 247 | 0.96 | 237.12 | 145 | SEC |
| 2025-12-30 | 12-30 | Jin David | Director | P 公開市場買進 | 247 | 0.96 | 237.12 | 286 | SEC |
| 2025-09-29 | 10-01 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 59.3K | – | – | 258K | SEC |
| 2025-04-24 | 04-28 | Litchman Manuel MD | President, CEO and Interim CFO | F 繳稅扣股 | 27 | 1.24 | 33.48 | 1.6K | SEC |
| 2025-03-31 | 04-02 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 67.8K | – | – | 199K | SEC |
| 2024-06-27 | 06-28 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 575K | – | – | 2.5M | SEC |
| 2024-05-31 | 06-04 | Litchman Manuel MD | President and CEO | F 繳稅扣股 | 1.4K | 0.35 | 488.60 | 83.0K | SEC |
| 2024-01-02 | 01-03 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 419K | – | – | 1.9M | SEC |
| 2023-07-05 | 07-07 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 7.2K | – | – | 60.5K | SEC |
| 2023-07-05 | 07-07 | ZELEFSKY MICHAEL J | Director | A 獲配股票 | 7.2K | – | – | 19.0K | SEC |
| 2023-07-05 | 07-07 | Chill Adam J. | Director | A 獲配股票 | 7.2K | – | – | 19.2K | SEC |
| 2023-07-05 | 07-07 | Herskowitz Neil | Director | A 獲配股票 | 7.2K | – | – | 19.7K | SEC |
| 2023-07-05 | 07-07 | WEISS MICHAEL S | Director | A 獲配股票 | 7.2K | – | – | 49.6K | SEC |
| 2023-04-24 | 06-04 | Litchman Manuel MD | President and CEO | F 繳稅扣股 | 1.6K | 4.21 | 7K | 79.4K | SEC |
| 2023-04-24 | 07-07 | Litchman Manuel MD | President and CEO | A 獲配股票 | 5.0K | – | – | 111K | SEC |
| 2023-01-06 | 01-06 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 2.8M | – | – | 22.6M | SEC |
| 2022-09-13 | 04-03 | Litchman Manuel MD | Director | P 公開市場買進 | 5.0K | 0.52 | 3K | 1.1M | SEC |
| 2022-09-13 | 04-03 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 5.0K | 0.52 | 3K | 299K | SEC |
| 2022-07-29 | 04-03 | Herskowitz Neil | Director | A 獲配股票 | 71.7K | – | – | 187K | SEC |
| 2022-07-29 | 04-03 | WEISS MICHAEL S | Director | A 獲配股票 | 71.7K | – | – | 136K | SEC |
| 2022-07-29 | 04-03 | Chill Adam J. | Director | A 獲配股票 | 71.7K | – | – | 179K | SEC |
| 2022-07-29 | 04-03 | ZELEFSKY MICHAEL J | Director | A 獲配股票 | 71.7K | – | – | 176K | SEC |
| 2022-07-29 | 04-03 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 71.7K | – | – | 294K | SEC |
| 2022-06-21 | 04-03 | Litchman Manuel MD | Director | A 獲配股票 | 61.0K | – | – | 1.1M | SEC |
| 2022-04-24 | 06-04 | Litchman Manuel MD | President and CEO | F 繳稅扣股 | 1.2K | 12.15 | 15K | 81.0K | SEC |
| 2022-03-18 | 04-03 | Litchman Manuel MD | Director | P 公開市場買進 | 5.0K | 0.74 | 4K | 1.0M | SEC |
| 2022-03-18 | 04-03 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 4.1K | 0.74 | 3K | 223K | SEC |
| 2021-12-14 | 12-16 | Achenbach Brian | SVP, Fin. & Corp. Controller | S 公開市場賣出 | 4.4K | 1.83 | 8K | 145K | SEC |
| 2021-12-08 | 12-16 | Achenbach Brian | SVP, Fin. & Corp. Controller | A 獲配股票 | 22.5K | – | – | 149K | SEC |
| 2021-10-27 | 11-08 | Litchman Manuel MD | President and CEO | P 公開市場買進 | 65.0K | 2.24 | 146K | 1.0M | SEC |
| 2021-10-12 | 10-21 | Achenbach Brian | SVP, Fin. & Corp. Controller | S 公開市場賣出 | 4.5K | 2.28 | 10K | 127K | SEC |
| 2021-08-31 | 09-24 | Litchman Manuel MD | President and CEO | A 獲配股票 | 2.7K | 2.58 | 7K | 963K | SEC |
| 2021-08-31 | 09-24 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 1.2K | 2.58 | 3K | 218K | SEC |
| 2021-07-30 | 08-05 | Litchman Manuel MD | President and CEO | P 公開市場買進 | 86.2K | 2.91 | 251K | 960K | SEC |
| 2021-06-28 | 07-08 | Chill Adam J. | Director | A 獲配股票 | 13.8K | – | – | 107K | SEC |
| 2021-06-28 | 07-08 | Herskowitz Neil | Director | A 獲配股票 | 13.8K | – | – | 115K | SEC |
| 2021-06-28 | 07-08 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 13.8K | – | – | 217K | SEC |
| 2021-06-28 | 07-08 | WEISS MICHAEL S | Director | A 獲配股票 | 13.8K | – | – | 64.2K | SEC |
| 2021-06-28 | 07-08 | ZELEFSKY MICHAEL J | Director | A 獲配股票 | 13.8K | – | – | 104K | SEC |
| 2021-06-17 | 07-08 | Litchman Manuel MD | President and CEO | A 獲配股票 | 61.0K | – | – | 874K | SEC |
| 2021-04-09 | 04-16 | Achenbach Brian | SVP, Fin. & Corp. Controller | S 公開市場賣出 | 2.4K | 3.36 | 8K | 131K | SEC |
| 2021-03-05 | 03-15 | Litchman Manuel MD | President and CEO | P 公開市場買進 | 166K | 3.12 | 517K | 825K | SEC |
| 2021-02-26 | 03-15 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 1.0K | 2.83 | 3K | 203K | SEC |
| 2021-02-26 | 03-15 | Litchman Manuel MD | President and CEO | A 獲配股票 | 5.0K | 2.83 | 14K | 660K | SEC |
| 2020-12-15 | 03-15 | Achenbach Brian | SVP, Fin. & Corp. Controller | A 獲配股票 | 22.5K | – | – | 152K | SEC |
| 2020-12-15 | 12-22 | Litchman Manuel MD | President and CEO | P 公開市場買進 | 100K | 2.91 | 291K | 655K | SEC |
| 2020-12-14 | 12-22 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 100K | 2.66 | 266K | 202K | SEC |
| 2020-12-14 | 12-15 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 100K | 2.66 | 266K | 200K | SEC |
| 2020-12-08 | 04-16 | Achenbach Brian | SVP, Fin. & Corp. Controller | S 公開市場賣出 | 5.2K | 3.03 | 16K | 133K | SEC |
| 2020-10-21 | 04-16 | Achenbach Brian | SVP, Fin. & Corp. Controller | S 公開市場賣出 | 3.1K | 2.97 | 9K | 139K | SEC |
| 2020-09-15 | 12-22 | Litchman Manuel MD | President and CEO | A 獲配股票 | 61.0K | – | – | 555K | SEC |
| 2020-08-31 | 12-22 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 1.2K | 2.48 | 3K | 102K | SEC |
| 2020-08-31 | 12-22 | Litchman Manuel MD | President and CEO | A 獲配股票 | 5.0K | 2.48 | 12K | 494K | SEC |
| 2020-07-14 | 12-22 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 16.6K | 2.48 | 41K | 101K | SEC |
| 2020-07-14 | 08-19 | Herskowitz Neil | Director | A 獲配股票 | 16.6K | – | – | 101K | SEC |
| 2020-07-14 | 08-19 | ZELEFSKY MICHAEL J | Director | A 獲配股票 | 16.6K | – | – | 90.4K | SEC |
| 2020-07-14 | 08-19 | WEISS MICHAEL S | Director | A 獲配股票 | 16.6K | – | – | 50.4K | SEC |
| 2020-07-14 | 08-19 | Chill Adam J. | Director | A 獲配股票 | 16.6K | – | – | 93.4K | SEC |
| 2020-07-14 | 08-19 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 16.6K | – | – | 100K | SEC |
| 2020-06-11 | 06-15 | Litchman Manuel MD | President and CEO | P 公開市場買進 | 154K | 3.25 | 500K | 489K | SEC |
| 2020-05-22 | 04-29 | Litchman Manuel MD | President and CEO | S 公開市場賣出 | 4.0K | 3.04 | 12K | 821K | SEC |
| 2020-05-22 | 04-29 | Litchman Manuel MD | President and CEO | S 公開市場賣出 | 8.3K | 3.04 | 25K | 813K | SEC |
| 2020-05-22 | 04-16 | Achenbach Brian | SVP, Fin. & Corp. Controller | S 公開市場賣出 | 880 | 3.04 | 3K | 142K | SEC |
| 2020-05-21 | 05-22 | Litchman Manuel MD | President and CEO | P 公開市場買進 | 90.0K | 3.13 | 282K | 335K | SEC |
| 2020-05-14 | 05-22 | Litchman Manuel MD | President and CEO | P 公開市場買進 | 90.0K | 2.79 | 251K | 245K | SEC |
| 2020-03-31 | 04-16 | Achenbach Brian | SVP, Fin. & Corp. Controller | S 公開市場賣出 | 3.0K | 2.64 | 8K | 143K | SEC |
| 2020-03-26 | 04-29 | Litchman Manuel MD | President and CEO | A 獲配股票 | 122K | – | – | 155K | SEC |
| 2020-03-26 | 04-29 | Achenbach Brian | SVP, Fin. & Corp. Controller | A 獲配股票 | 36.3K | – | – | 129K | SEC |
| 2020-03-05 | 04-29 | Achenbach Brian | SVP, Fin. & Corp. Controller | A 獲配股票 | 524 | 2.48 | 1K | 93.0K | SEC |
| 2020-03-05 | 04-29 | Litchman Manuel MD | President and CEO | A 獲配股票 | 5.0K | 2.48 | 12K | 33.0K | SEC |
| 2020-02-28 | 12-22 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 831 | 2.48 | 2K | 84.6K | SEC |
| 2019-12-06 | 04-16 | Achenbach Brian | SVP, Fin. & Corp. Controller | S 公開市場賣出 | 6.1K | 3.69 | 23K | 146K | SEC |
| 2019-08-28 | 01-17 | ROSENWALD LINDSAY A MD | Director | A 獲配股票 | 13.8K | – | – | 83.8K | SEC |
| 2019-08-28 | 01-17 | WEISS MICHAEL S | Director | A 獲配股票 | 13.8K | – | – | 33.8K | SEC |
| 2019-08-28 | 01-17 | Chill Adam J. | Director | A 獲配股票 | 13.8K | – | – | 76.8K | SEC |
| 2019-08-28 | 01-17 | Herskowitz Neil | Director | A 獲配股票 | 13.8K | – | – | 84.8K | SEC |
| 2019-04-16 | 01-17 | Achenbach Brian | SVP, Fin. & Corp. Controller | A 獲配股票 | 35.0K | – | – | 92.5K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Kestra Advisory Services, LLC | 197K | 138K | +20.9K (+12%) | 加碼 |
| BlackRock, Inc. | 84.7K | 59K | 不變 | 持平 |
| 城堡 CITADEL ADVISORS LLC | 59.5K | 42K | +6.3K (+12%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 42.2K | 30K | −50.5K (-54%) | 減碼 |
| CFO4Life Group, LLC | 33.5K | 24K | +13.0K (+64%) | 加碼 |
| VANGUARD FIDUCIARY TRUST CO | 32.1K | 23K | 不變 | 持平 |
| VANGUARD CAPITAL MANAGEMENT LLC | 25.7K | 18K | 不變 | 持平 |
| XTX Topco Ltd | 14.6K | 10K | 新進 | 新進 |
| TWO SIGMA SECURITIES, LLC | 13.7K | 10K | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13.7K | 10K | 新進 | 新進 |
| UBS Group AG | 4.2K | 3K | +496 (+14%) | 加碼 |
| Tower Research Capital LLC (TRC) | 1.9K | 1K | 不變 | 持平 |
| BARCLAYS PLC | 1.1K | 787.00 | 新進 | 新進 |
| SBI Securities Co., Ltd. | 509 | 357.00 | 不變 | 持平 |
| MORGAN STANLEY | 118 | 83.00 | 不變 | 持平 |
| Virtu Financial LLC | 14.4K | 10.00 | 新進 | 新進 |
| Cullen/Frost Bankers, Inc. | 13 | 9.00 | 不變 | 持平 |
| BNP PARIBAS FINANCIAL MARKETS | 6 | 4.00 | 不變 | 持平 |
| LANARK FINANCIAL, INC. | 3 | 2.00 | 不變 | 持平 |
| DANSKE BANK A/S | 2 | 1.00 | 不變 | 持平 |
| OSAIC HOLDINGS, INC. | 2 | 1.00 | 不變 | 持平 |
| GROUP ONE TRADING LLC | 1 | 1.00 | 不變 | 持平 |
| JPMORGAN CHASE & CO | 2 | 1.00 | 不變 | 持平 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 23 +1 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 5 / 4 / 4 / 1 |
| 機構合計持股 · 佔流通股 | 539K · 2.2% |
| 合計季末市值 | 368K |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 55.0K |
|---|---|
| 與上期比 | +4.7% |
| 佔流通股數 | 0.22% |
| 日均成交量 | 15.5K |
| 回補天數 | 3.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 55.0K | +4.7% | 0.22% | 15.5K | 3.6 |
| 2026-08-14 | 52.6K | -4.7% | 0.21% | 36.8K | 1.4 |
| 2026-07-31 | 55.1K | -9.4% | 0.22% | 28.7K | 1.9 |
| 2026-07-15 | 60.9K | -40.6% | 0.24% | 42.0K | 1.5 |
| 2026-06-30 | 102K | -32.0% | 0.41% | 49.6K | 2.1 |
| 2026-06-15 | 151K | +176.0% | 0.60% | 554K | 1.0 |
| 2026-05-29 | 54.6K | +1.8% | 0.22% | 45.5K | 1.2 |
| 2026-05-15 | 53.6K | -25.7% | 0.21% | 40.8K | 1.3 |
| 2026-04-30 | 72.1K | -28.7% | 0.29% | 42.1K | 1.7 |
| 2026-04-15 | 101K | -19.4% | 0.40% | 34.7K | 2.9 |
| 2026-03-31 | 125K | +48.1% | 0.50% | 37.9K | 3.3 |
| 2026-03-13 | 84.7K | -36.8% | 0.34% | 36.3K | 2.3 |
| 2026-02-27 | 134K | -39.1% | 0.54% | 37.5K | 3.6 |
| 2026-02-13 | 220K | +405.2% | 0.88% | 772K | 1.0 |
| 2026-01-30 | 43.6K | +8.6% | 0.17% | 47.6K | 1.0 |
| 2026-01-15 | 40.1K | -22.1% | 0.16% | 62.4K | 1.0 |
| 2025-12-31 | 51.5K | -12.3% | 0.21% | 102K | 1.0 |
| 2025-12-15 | 58.8K | -32.3% | 0.24% | 79.4K | 1.0 |
| 2025-11-28 | 86.7K | +22.2% | 0.35% | 121K | 1.0 |
| 2025-11-14 | 71.0K | +16.0% | 0.28% | 88.6K | 1.0 |
| 2025-10-31 | 61.2K | -10.6% | 0.24% | 98.5K | 1.0 |
| 2025-10-15 | 68.4K | +12.6% | 0.27% | 143K | 1.0 |
| 2025-09-30 | 60.8K | -26.6% | 0.24% | 99.2K | 1.0 |
| 2025-09-15 | 82.7K | -43.5% | 0.33% | 133K | 1.0 |
| 2025-08-29 | 146K | -17.6% | 0.59% | 104K | 1.4 |
| 2025-08-15 | 177K | +31.0% | 0.71% | 190K | 1.0 |